A Lewiston doctor is the first to offer iDose to glaucoma patients in Maine. The tiny device holds up to 3 years' worth of ...

Expert Rev Ophthalmol. 2010;5(3):405-412. Benzalkonium chloride is the most common preservative in antiglaucoma preparations and its toxic effects depend on the dose and duration of exposure. Chronic ...

As glaucoma management evolves toward earlier intervention, the question of when and how to escalate treatment remains ...

Please provide your email address to receive an email when new articles are posted on . More than half of all patients treated with glaucoma medications have ocular surface disease, which ...

MVCD: Microvascular complications of diabetes. Medical therapies are the mainstay of treatment for glaucoma and macular diseases, which are the leading causes of irreversible blindness worldwide.

Please provide your email address to receive an email when new articles are posted on . A 75-year-old man was referred to the retina service by his comprehensive ophthalmologist for high-risk ...

Across the world, some 80 million people suffer from glaucoma, a number that’s expected to swell to 111 million by 2040. Today, an estimated three million have been diagnosed in the United States. But ...

A steroid alternative may offer a new way to treat dry eye by restoring the eye’s natural protective defenses.

Glaucoma may result in severe dryness and irritation to the eyes as the disease progresses. Applying a warm compress or heated eye mask may help relieve symptoms for some people, but it’s not a formal ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

Those tiny dots, squiggles and cobweb-like specks drifting across your vision can be maddening—especially when you're trying to read a recipe, drive to the grocery store or simply enjoy an afternoon ...